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ABSTRACT   
 
BACKGROUND: Normal pregnancy is characterized by profound 
changes in almost every organ and system. Immunohematological 
parameters are important in clinical practice for the assessment of 
health and disease. Therefore, this study was aimed to establish 
immunohematological reference range among HIV sero-negative 
pregnant women.    
METHODS: A cross-sectional study was conducted among HIV 
sero-negative pregnant women at St. Paul’s Hospital Millennium 
Medical College (SPHMMC), Addis Ababa, Ethiopia, from 20/1-
30/6/ 2016. Whole blood was collected and immunological and 
hematological parameters were measured following the standard 
procedure. Data were entered in to  Epi Info version 3.5, checked 
for completeness and exported to SPSS version 20 software for 
analysis. The mean ± SD and 95% Confidence Interval (95% CI) 
values were calculated for different immunohematological 
parameters. 
RESULTS: A total of 400 women with mean age ±SD (27.3 ±4.7) 
ranging from18-40 years were enrolled. The mean ± SD reference 
value of white blood cells count with 95% CI was 8.3 ±2.3  (8.1-8.6) 
x10
9




, and CD4to CD8 ratio cells 
absolute count with 95% CI were 906 ±404 (867-946), 698± 378 
(662-736) cell/μl, and 1.5±0.9 (1.4-1.6), respectively.  
The mean ± SD reference values for red blood cells count with 95% 
CI was 4.5±0.5(4.4-4.5) 10
12
/L, for hemoglobin 14±7.2(13.3-14.7) 
gm/dl, and for hematocrite was 39.5± 4(39-39.9).  
CONCLUSIONS: These values were lower than the one from 
developed countries but not lower than the one from other African 
studies. It suggests the need for further large study.   
KEYWORDS: Immunohematological References, Pregnant 
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Reference value results are obtained by 
measurement of a particular type of quantity on an 
adequate number of persons in the selected group 
to represent the general population (1). These 
values are influenced by many factors in general 
and pregnancy in particular (1,2). Pregnancy is a 
state characterized by many immunohematological 
changes, which may appear to be pathological in 
the non-pregnant state because the fetus faces a 
complex set of immunological demands, 
avoidance of harmful inflammatory immune 
responses that can lead to pre-term delivery (3). 
Haematological and immunological reference 
ranges are important in clinical practice for the 
assessment of health and disease. However, 
inappropriate reference values may increase the 
risk of either unnecessary additional investigations 
or mismanagement of patients. Therefore, 
addressing those issues properly, it is useful for 
measuring disease progression, response to 
therapy, and in the assessment of adverse reactions 
to therapy (4).  
Many of the hematological indices are 
influenced by many factors like sex, seasonal 
variation, lactation, pregnancy health and 
nutritional status (5). It is also acknowledged that 
for comparisons between individuals and with 
reference data in a clinical diagnostic situations, it 
is necessary to consider the normal variations (6).  
As one  study revealed, there were significant 
decreases in RBCs count, hemoglobin (Hgb) and 
packed cell volume (PCV) of pregnant women 
compared to non-pregnant women. This study also 
showed total white blood cells count was 
increased significantly (7) and increased level of 
appetite too (8).  Anemia (low hemoglobin) is a 
widely identified hematological abnormality (9), 
and it is associated with adverse pregnancy 
outcomes (10).  
Although a single study which determines 
immunohematological reference values has been 
done among factory workers, 
immunohematological reference values for 
pregnant women in Ethiopia have never been 
established (11). However, few attempts were 
made to determine hemoglobin and hematocrit 
levels in some populations (12,13). 
The immunohematological reference values 
which are currently used in the country are 
adopted from textbooks which refer mainly to 
non-Ethiopian subjects. Hence, the need to 
establish Ethiopian immunohematological 
reference values for pregnant women is mandatory 
especially in monitoring of HIV/AIDS and 
anemia. In addition, this study is important 
because an attempt to predict and/or improve 
pregnancy outcomes during antenatal care are 
dependent on immunohaematological indices. 
Therefore, the present study was aimed to 
determine immunohematological reference values 
among HIV sero-negative pregnant women. 
 
MATERIALS AND METHODS 
 
Study Design and Setting: Institution based cross 
sectional study was carried out at ANC clinics at 
St. Paul’s Hospital Millennium Medical College 
(SPHMMC), Addis Ababa, Ethiopia, from 
01/03/2016 – 30/03/2016. SPHMMC is a referral 
hospital in Addis Ababa under the Ethiopian 
Federal Ministry of Health (FMOH). It has 13 a 
departments out of which antenatal care (ANC) 
clinics, and laboratory departments are among the 
lists. The document obtained from the hospital 
indicate that 27, 780 individuals used ANC service 
and 131,256 individuals served for hematology 
laboratory tests per year.    
Source population: All pregnant women 
attending ANC clinics at St. Paul’s Hospital 
Millennium Medical College (SPHMMC), Addis 
Ababa, Ethiopia, was the source population. 
Study population: The study population was 
apparently health HIV sero-negative pregnant 
women attending ANC clinics at St. Paul’s 
Hospital Millennium Medical College 
(SPHMMC), Addis Ababa, Ethiopia, during the 
study period for antenatal followup.   
Sample size determination: The sample size was 
determined based on the recommended guide line 
of Clinical and Laboratory Standards Institute 
(CLSI). 
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Sampling technique: We reviewed daily recorded 
data from antenatal clinics. We calculated the 
daily average pregnant women flow who attended 
the antenatal clinics. Finally, study subjects were 
selected through systematic random sampling 
method. 
Inclusion criteria: People were included up to 
50km from Addis Ababa if they lived at least for 6 
months in their residence. Their age should be 18 
years and above. The absence of active clinical 
disease conditions, being pregnant and free of 
HIV-1/2, syphilis and hepatitis B antibodies in 
their serum were the inclusion criterias. 
Exclusion criteria: Any pregnant women who 
had febrile illness like mycobacterium 
tuberculosis and malaria and chronic 
noninfectious disease like allergy and arthritis and 
diabetes mellitus were excluded. Additionally, any 
vaccination in the past 6 months, taking steroid 
therapy in the past three months, any antibiotic 
usage four weeks prior to enrollment and using 
iron supplement, blood transfusion in the past 6 
months were excluded from the study. 
 
Data collection instrument 
Socio-demographic and clinical data: After 
obtaining informed consent, structured pre-tested 
questionnaire was used to collect socio-
demographic and clinical data. Socio-demographic 
data were age, marital status, educational status, 
occupation, monthly income, nutritional status, 
gestational age, smoking habit and the use of 
alcohol consumption. Clinical data were gathered 
for the presence and absence of active disease like 
diabetes mellitus and allergies. Uses of steroid 
therapy for the last three month, blood and blood 
product transfusion or vaccination for the past six 
months were also assessed. Both the clinical and 
socio-demographic data were taken from pregnant 
women by antenatal care (ANC) providers 
working at ANC clinics. 
Blood sample collection and processing: Whole 
blood was collected with a vacutainer system in 
10-ml tubes containing EDTA from consented 
pregnant women. All samples were collected 
between 7:00 and 12:00 a.m. to minimize 
circadian variation at the ANC clinics. HIV status 
of the study participants were determined by rapid 
test following the national HIV Rapid Testing 
Algorithm. Absence of sero status of syphilis and 
hepatitis B were confirmed using rapid strip 
immunoassay techniques at the ANC clinics, and 
sero-negative samples were analyzed in the 
laboratory on the same day of sample collection. 
Hematological analysis: The CELL-DYN 1800 
was used. The CELL-DYN 1800 aspirates 
approximately 30μL (microliters) of whole blood 
from an open collection tube that has been held 
under the Sample Aspiration Probe, and transfers 
the sample to the Pre-Mixing Cup. The CELL-
DYN 1800 is designed to automatically perform 
the following functions: Aspirate and dilute 
whole blood, Count, size and classify cells 
present in a whole blood specimen, Analyze raw 
data collected, and Output results to the display, 
printer and on-line computer. 
This instrument is designed to classify the 
following formed elements of EDTA-
anticoagulated blood: White Blood Cell 
Parameters such as WBC—White Blood Cell or 
leukocyte count, %GRAN—Granulocyte percent, 
%LYM—Lymphocyte percent, %MXD-Mixed 
cells (mononuclear, Eosinophil and Basophil cells 
together in percent), PLT—Platelet count, MPV—
Mean Platelet Volume. Red Blood Cell 
Parameters: RBC—Red Blood Cell or 
erythrocyte count,  Hct—Hematocrit,  MCV—
Mean Cell Volume,  RDW—Red Cell Distribution 
Width. Hemoglobin Parameters: HGB—
Hemoglobin concentration, MCH—Mean Cell 
Hemoglobin, MCHC—Mean Cell Hemoglobin 
Concentration is used for whole-blood analysis of 
hematological parameters. The machine 
automatically dilutes a whole-blood sample of 
29.6 μl, lyses, counts and gives a printout result of 
absolute numbers of leukocytes (WBC) (expressed 
as number of cells × [10
9
] per liter), erythrocytes 
(RBC) (number of cells × [10
12
] per liter), platelets 
(number of cells × [10
9
] per liter), lymphocytes 
(number of cells in percent), mixed cells for 
mononuclear cells, eosinophil and basophils 
(number of cells in percent), granulocytes (number 
of cells × [10
9
] per liter),  hemoglobin (in grams 
per deciliter) and hematocrit (in percent).  
Immunological analysis: The FACS Calibur 
system, a modular bench top flowcytometer from 
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Becton Dickinson Immunocytometry Systems 
(BDIS) was used. It consists of a sensor module, 
a computer module and various software 
packages. Designed for applications that ranged 
from routine clinical to advanced research, this 
system analyzes cells as they pass one at a time 
through a focused laser beam. The FACS Calibur 
system can measure several parameters, including 
forward light scatter (FSC), side light scatter 
(SSC) and several fluorescence parameters plus 
the pulse area and width of any fluorescence 
parameter. 
As a cell passes through the laser, the FACS 
Calibur electronics system, using the sort gate 
characteristics, quickly determines whether that 
cell is a cell of interest (target cell). The target cell 
is then captured according to the preselected sort 
mode. Because laser alignment and stream 
velocity are fixed, the time it takes for desired 
cells to travel from the laser intercept to the 
catcher tube is constant. When the decision is 
made to capture the target cell, the electronics 
waits for a fixed period of time to allow the cell to 
reach the catcher tube and then triggers the catcher 
tube to swing into the sample stream to capture the 
cell. 
Lymphocyte subsets were analyzed using a 
FACS Calibur flow cytometer (Becton Dickinson 
Immunocytometry Systems, San Jose, Calif.) with 
two monoclonal antibodies (aCD4 and a CD8; 
Becton Dickinson Immunocytometry Systems). In 
brief, 100μl of whole blood was mixed and 
incubated at room temperature for 20 minutes with 
10μl of CD4 and CD8 monoclonal antibodies. 
RBCs were lysed by adding 2ml of fluorescence-
activated cell sorter lysing solution (Becton 
Dickinson Immunocytometry Systems). After 
vortexing, tubes were incubated in the dark at 
room temperature for 10 minutes. 
Data quality control: The English version of the 
structured questionnaire was translated in to 
Amharic and was pretested on pregnant women 
attending ANC clinics at Black Lion Hospital, 
Addis Ababa, Ethiopia, to check its validity. 
According to the pretest, some amendments or 
corrections were made. Manufacturer’s 
instructions were strictly followed for each of the 
tests during laboratory work. Moreover, in order 
to ensure accuracy and precision of the test run, 
the instruments were calibrated daily by running 
known values of control before the start of the test 
or whenever new lots of the reagents were 
changed. 
Data analysis procedure: Data were entered in to 
Epi Info version 3.5.1, checked for completeness 
and exported to SPSS version 20 software for 
analysis. Descriptive analysis was made to 
determine the socio-demographic and clinical 
characteristics of thr study participants. The mean, 
standard deviation and 95% CI values were 
calculated for immunohematological parameters. 
Ethical considerations: Ethical clearance was 
secured from the Ethical Review Committee of 
SPHMMC. The purposes and the importance of 
the study were explained, and written consent was 
taken from participants. Participants, who had 
HIV infections, were referred to the HIV care and 
treatment clinic for further management after post 




A total of four hundred (400) study participants 
(100 for 1
st
 trimester, 150 for 2
nd
 trimester and 150 
for 3
rd
 trimester) pregnant women were included. 
Socio-demographic characteristics: The mean 
age ± SD of the women was (27.3 ± 4.7) and 
ranged from18-40 years. The majority of the 
participants were 42% (n=168) educated Grade 1-
8
th
, 29.8% (n=119) Oromo ethnic group, 51.8% 
(n=207) Orthodox religion follower, 58.5% 
(n=234) House Wife regarding  occupational 
status. Half of the participants had 1072-1571Birr 
monthly income according to Ethiopian salary in 
public procurement and property disposal service 
and  97.3% (n=390) were married. Regarding their 
addresses, 244(61%) of the participants were from 
SPHMMC whereas 156(39 %) were referred from 
other health institutions. Concerning their socio-
demographic characteristics, the mean age of the 
participant was 27.3±4.7, and had a body mass 
index (BMI) of 24.3±3.8 kg/m
2
. 
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Table 1: Socio-demographic characteristics among HIV Sero-negative Pregnant Women at St. Paul’s 
Hospital Millennium Medical College (SPHMMC), Addis Ababa, Ethiopia, from 01/03/2016 – 30/03/2016. 
 
 




<21 yrs 41(10.3) 
21-25 yrs 115(28.8) 
26-30 yrs 162(40.5) 
31-35 yrs 61(15.3) 











Diploma  34(8.5) 







 SNNP 147(36.8) 
Others 2(0.5) 
Religion Orthodox 207(51.8) 
Muslim 143(35.8) 
 Protestant 46(11.5) 
Catholic 4(1.0) 
 House Wife 234(58.5) 
Occupation Private workers 90(22.5) 
 Government Employee 44(11.0) 
 Merchant 16(4.0) 
 Farmer 13(3.3) 
 Others 3(0.8) 
Monthly Income <817 Birr 56 (14) 
 1072-1571 Birr 202(50.5) 
 >2058 Birr 142(35.5) 
 
We established the mean ± SD reference values 
with 95
th
 CI of immunohematological values for 





cells/L) was 8.3± 2.3(8.1-8.6), RBC 
(X10
12
cells/L) 4.5±0.5 (4.4-4.5) and Platelet 
(x10
9






               
   
                 Ethiop J Health Sci.                           Vol. 27, No. 6                      November 2017 
 
 




Table 2: Mean ± SD (95% CI) Immunohematological Values, among HIV Sero-negative Pregnant Women 
with their gestational category at St. Paul’s Hospital Millennium Medical College (SPHMMC), Addis 






 (1-13wks), N=100 
2
nd










cells/L) 7.3±2.01(6.5-8) 8.3±2.3 (8-8.7) 8.5±2.3 (8-8.8) 8.3 ±2.3 (8.1-8.6) 
Neutrophil (%) 64±10.9 (60-68) 69±6.9 (68-70) 67± 8.9(65.6-68) 67.9 ±8.4 (67-68.7) 
Mixed (%) 9.4± 6.4(7-12) 8.5± 3.7(8-9) 9±6.1 (8-10) 8.8±5.2 (8.3-9.3) 
Lymphocyte (%) 27± 8.3(23.4-30) 22.5±5.9 (21.6-23.4) 24± 7.3(23-25) 23.6 ± 7(23-24.3) 
Platlet(x10
9
cells/L) 240±71.4(212-267) 230±65.3 (220-239) 226±69.3(216-235) 228± 68(221.6-235) 
CD4
+
 (cells/μl) 802±260(700-903) 885±370 (830-941) 940±444(878-1002) 906± 404(867-946) 
CD8
+
 (cells/μl) 591± 252(494-689) 658± 319(610-706) 750±430 (690-810) 698 ± 378(662-736) 
CD4:CD8 Ratio 1.5±0.6 (1.3-1.7) 1.5±0.5 (1.4-1.6) 1.5±1.2 (1.3-1.7) 1.5 ± 0.9(1.4-1.6) 
RBC (X10
12
cells/L) 4.8±0.54(4.6-5) 4.5± 0.5(4.4-4.5) 4.5±0.5 (4.4-4.6) 4.5 ±0.5 (4.4-4.5) 
Hgb (gm/dl) 14.3±1.7 (13.7-15) 14.3± 1.1(12.6-16) 13.8± 1.5(12.6-14) 14 ± 7.2(13.3-14.7) 
Hct (%) 41.4±4.7(40-43) 39±3.9(38-40) 40± 4(39-40) 39.5 ±4.0 (39-39.9) 
MCV (fl) 87±4.0 (85-88) 88±5.8 (86.7-88.4) 89±5.7 (88-89) 88 ± 5.7(87.4-88.5) 
MCH (pg/dl) 30±1.5 (29.4-30.5) 30±2.2 (30-30.6) 30.7± 2.3(30.4-31) 30.5 ±2.2 (30-30.7) 
MCHC (g/dl) 34.6±1.2(34-35) 34.6± 1.5(34.4-34.8) 34.7±1.4 (34.5-35) 34.6±1.4(34.5-34.8) 
     
    WBC=White Blood Cell count, Mixed=mixed cell, CD+= Cluster of Differentiation positive cells, RBC= Red Blood 
Cell, Hgb= Hemoglobin, Hct= Hematocrite, MCV = mean corpuscular volume, MCH = mean corpuscular 
Hemoglobin, MCHC = mean corpuscular hemoglobin concentration, CI=Confidence Interval 
 
In order to estimate the reference intervals that 
might change with age, the mean and 95
th
 
confidence intervals were establish by age 
partition  for WBC, platelets (Table 3 and 4), RBC 
and  their indices (Tables 5 and 6). The mean 
(95%CI) for MCV and MCHC nearly increase as 
the age groups classification increases whereas 
RDW appears to be decreased (Table 6). 
    Table 3: Distribution mean value with 95% CI WBC, Platelet and Differential count, among HIV Sero-
negative Pregnant Women by age groups at St. Paul’s Hospital Millennium Medical College (SPHMMC), 



















Mean (95% CI) Mean (95% CI) Mean(95%CI) Mean(95% CI) Mean(95% CI) Mean (95% CI) 
<21yr 41 233 (215-251) 11(10.3-11.3) 8.3 (7.6-8.9) 68 (65.5-70.6) 8.3 (7.3-9.1) 23.6(21-25.9) 
21-25 115 234 (220-248) 10.1 (9.9-10.3) 8.4(7.9-8.9) 68 (66.4-69.6) 8.6(7.6-9.6) 23.2(22-24.4) 
26-30 162 224 (214-248) 10.3 (10-10.4) 8.3 (8.0-8.7) 68 (66.9-69.5) 8.7(7.8-9.6) 23.4(22-24.6) 
31-35 61 231 (214-248) 10.1 (9.8-10.4) 8.2 (7.6-8.7) 67.2(65-69.4) 9.3 (8.1-10.5) 24(22.3-25.9) 
>36  21 212 (192-232) 10.3 (9.9-10.7) 8.1 (7-9.3) 65.8 (62.4-69) 10.3 (7-13.4) 25 (22-28.3) 
Total 400 228(221.6-235) 10.3 (10-10.4) 8.3 (8.1-8.6) 67.9  (67-68.7) 8.8  (8.3-9.3) 23.6(23-24.3) 
 
WBCs= White Blood Cells, MPV=Mean Platelet Volume 
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, and CD4 to CD8 ratio count, among 
HIV Sero-negative Pregnant Women by age groups at St. Paul’s Hospital Millennium Medical College 


















Mean (95% CI) 
CD4:CD8 Ratio 
Mean (95% CI) 
<21 41 1550(1383.9-1716.4) 815(738-893) 662(561-763) 1.3(1.1-1.4) 
21-25 115 1498(1389-1607) 815(754-877) 606(554-657) 1.5(1.4-1.6) 
26-30 162 1746 (1622-1871) 968(903-1033) 727(667-787) 1.5 (1.4-1.6) 
31-35 61 1808(1552-2063) 994 (857-1130) 794 (672-916) 1.7(1.2-2.2) 
>36 21 1899 (1178-2619) 859(706-1012) 788(579-997) 1.3(1.1-1.5) 
Total       400 1672(1591-1753) 906(867-946) 698(662-736) 1.5(1.4-1.6) 
 
Table 5: Distribution of Mean value with 95%CI of Red blood cells, Hemoglobin and Hematocrit, among 
HIV Sero-negative Pregnant Women by age groups at St. Paul’s Hospital Millennium Medical College 
(SPHMMC), Addis Ababa, Ethiopia, From 01/03/2016 – 30/03/2016. 
 
 










<21 41 4.5(4.3-4.7) 13.5(13-14) 39(38-40.5) 
21-25 115 4.5(4.4-4.6) 13.7(13.4-14) 39.7(39-40) 
26-30 162 4.4(4.4-4.5) 14.5(12.7-16) 39(38.8-39.8) 
31-35 61 4.5 (4.4-4.7) 13.7(13.3-14) 39.6(38.4-40.8) 
>36 21 4.5  (4.3-4.7) 13.9 (13.3-14.4) 39.5(37.9-41) 
Total N=400 4.5(4.4-4.5) 14 (13.3-14.7) 39.5(39-39.9) 
 
RBC=Red Blood Cell, Hgb= hemoglobin, Hct= Hematocrite, CI= Confidence Interval 
Table 6: Distribution mean value with 95% CI of RBC indices, among HIV Sero-negative Pregnant Women 
by age groups at St. Paul’s Hospital Millennium Medical College (SPHMMC), Addis Ababa, Ethiopia, 















<21 41 87(85-89) 30(29-30.6) 34.4(34-34.8) 14(13.7-14.7) 
21-25 115 87.4 (86.4-88.5) 30(29.8-30.7) 34.6(34-34.9) 14.3(14-14.6) 
26-30 162 88.6(87.7-89.5) 30.7 (30.4-31) 34.7(34.5-34.9) 14(14-14.3) 
31-35 61 87.6(86-89) 30.5(30-31) 34.8(34-35) 14(13.6-14.7) 
>36 21 88.8(86.6-91) 31(30-32) 35(34.5-35.4) 13.8(13.5-14) 
Total 400 88(87.4-88.5) 30.5(30.3-30.7) 34.6(34.5-34.8) 14.1 (14-14.3) 
 
MCV= Mean Corpuscular Volume, MCH= Mean Corpuscular Hemoglobin, MCHC= Mean Corpuscular Hemoglobin 
Concentration, RDW= Red Cell Width 
CV = mean corpuscular volume, MCH = mean corpuscular Hemoglobin, MCHC = mean 
DISCUSSION 
 
To the best of the authors’ knowledge, studies all 
over the world showed variability of 
immunohematological reference values 
particularly during pregnancy. Thus, reference 
values for pregnancy are  mandatory rather than 
applying results derived from healthy adults. 
However, no specific studies have been conducted 
on pregnant women in Ethiopia. 
We found slight increments of White blood 
cell counts (WBCs) and percent of mixed cells. 
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However, decline in absolute count of platelet and 
percent of Neutrophil concentration from the first 
to the third trimester observed. This rise of  
leukocytes during early pregnancy is well 
documented in the previous study (14).The 
increase observed in WBC count from the first to 
third trimester in this study is consistent with other 
findings (14,15), which reported exactly the same 
pattern. This condition may be due to a response 
for physiological pregnancy pain and anxiety 
without infection. A gradual reduction in PLT 
count as pregnancy advanced, which is also 
consistent with the study done on Lagos, 
Nigeria(15), may be due to hemodilution. 
Compared with other reference values 
established in Europe trimesters (WBC= 
8108±1853, 9086±1922,   9516±1853, 
Gran=73.5±4.9, 77.7±4.2, 79.9±5.1)(14) and the 
United States (WBC =9.5±3,  10.5±2.5,  10.8±3.2) 
(16), which we used as a reference, low values of 
WBC and granulocytes mean ±SD (95% CI) were 
found in each trimesters. The possible reason for 
these low values of variables may be genetic, 
nutritional or environmental variability. 
The RBC parameters of Ethiopia are 
consistently higher than those of many other 
African countries; overall mean ±SD of this study 
of Hgb was 14 ± 7.2, and for each trimester, 
values were 14.3±1.7, 14.3± 1.1, 13.8± 1.5 higher 
compared to the previous study of overall mean 
±SD of Hgband each trimester values conducted in 
Lagos, Nigeria (15). Concerning Hct values, also 
the overall mean ±SD; 39.5 ±4.0, and for each 
trimesters; 41.4±4.7, 39±3.9, 40± 4. These values 
were higher than the overall mean and each 
trimester studies done in Nigeria (15, 17). Again, 
the possible explanation for these higher values of 
RBC parameters may be high altitude and 
induction of erythropoiesis due to such altitudes. 
The absolute count of Red Blood Cells 
(RBCs) and the concentration of Hemoglobin 
(Hgb) gradually decrease from first to third 
trimester but a drop decrease in the percentage 
concentration of hematocrite in the second 
trimester observed. The progressive decline of the 
absolute count of RBC and Hgb concentration 
from the first to third trimester may be due to an 
increased demand for iron as pregnancy 
progresses. More iron is required to meet the 
expansion of maternal Hb mass and the needs of 
fetal growth, or it might be because of hormonal 
changes and fluid retention. 
The overall mean ±SD (95%  CI) of RBCs  
seems higher than  the previous report of 
Ethiopian reference values counts (11). This may 
happen because of the occurrence of 
erythropoiesis during pregnancy. However,  the 
current study of  Hgb and Hct is lower than the 
one from this earlier report of Hgb and Hct 
respectively (11). This may be due to  the results 
of physiological factor since the participants of the 
current study were pregnant. During pregnancy 
expansion of the plasma volume may lower Hgb 
and Hct value or may be a reflection of adequate 
iron  demand. 
As compared to another study done in 
Ethiopia, RBC, Hgb and Hct (18), the values 
reported in the current study  were higher. This 
may be because of the geographical location. Our 
study participants found at high altitude, and high 
altitude induced erythropoiesis for such variations. 
The red cell indices mean± SD and 95% reference 
values,  MCV appears to increase from the first to 
the third trimester while the MCH and  MCHC 
relatively show constant concentrations; this 
values are slightly increased from the study done 
in Nigeria (15). 
Regarding lymphocytes counts, relatively low 
percent of lymphocyte concentration was seemed 
to appeare in the second trimester whereas the 
absolute count of CD4
+
 cells and CD8
+
 T cells 
increase from the first to third trimesters. This 
relative reduction of lymphocyte indicates 
hemodilution as far as the absolute counts are not 
decreased. 
The present study values for CD4+, CD8+ 
and the ratio of CD4+ to CD8+ T cells mean ±SD 
(95% reference range) were higher than as 
compared to the earlier reports  adult reference 
values from Ethiopia (11). This lymphocytosis 
difference may be due to the difference in the 
study participants since lymphocytosis increase 
during pregnancy. As compared to other studies, 
the overall absolute count of mean ± SD for CD4
+
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) the study  
done in Dar es Salaam, Tanzania(19). Also the 
second and the third trimesters 
(885±370,940±444) seem to be appear higher than 
the study in USA (810±181, 800±179), 
respectively(16).The current study of overall mean 
±SD for absolute CD4 T-cell counts and CD8+T-
cells (940±444 and 750±430) were higher than the 
study conducted in India (764± 249 and 547 ± 
196) , respectively (20).The possible explanation 
may be environmental factor, i.e., in more 
prevalent parasitic infection, the probability of 
getting high absolute count for those lymphocyte 
will increase. 
In conclusion, reference values for HIV-
negative pregnant women are rare in the literature. 
In this study, we reported reference values of 
mean± SD with 95% CI of immunohematological 
counts of pregnant women in SPHMMC, Addis 
Ababa, Ethiopia. These values were lower than the 
from developed countries but not lower than the 
from other African studies. Except for absolute 
and percentage count for immunohematological 
values in the health institution, we found no 
evidence about the general population and 
regarding the function of immune cells too. We 
suggest further large scale investigations which 
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